In South Korea’s underground health forums, users are reporting alarming sexual side effects—including libido loss—after using a newly popularized “metabolic reset” supplement marketed as a “miracle diet aid.” Dubbed “Chakuyahongju” (초 카구야 공주, or “Princess Kakuyahongju”), this unregulated herbal blend, primarily sold via Korean e-commerce platforms and social media influencers, combines traditional botanicals (e.g., Rehmannia glutinosa, Cnidium officinale) with synthetic compounds like L-carnitine analogs and serotonin-modulating adaptogens. Regulatory agencies in both Korea and Japan have yet to classify it as a drug, leaving users vulnerable to misinformation and unmonitored adverse effects. This gap in oversight raises urgent questions: How do these compounds interact with hypothalamic-pituitary-gonadal (HPG) axis function? And why are patients—especially those with preexisting endocrine disorders—experiencing hypogonadotropic hypogonadism symptoms?
The core issue isn’t just the supplement itself, but the systemic failure to bridge traditional medicine with modern pharmacovigilance. While Korean herbalism has a 2,000-year history, the pharmacokinetic interactions between these compounds and synthetic additives remain unstudied in clinical trials. This week’s spike in forum reports—particularly among women aged 25–40—mirrors a broader trend: the global rise of unregulated “biohacking” diets that exploit loopholes in food supplement regulations. The World Health Organization (WHO) has warned that 20% of dietary supplements sold online contain undeclared pharmaceuticals, yet Korea’s Ministry of Food and Drug Safety (MFDS) lacks real-time monitoring tools for such products.
In Plain English: The Clinical Takeaway
- What’s in it? A mix of traditional herbs (e.g., Cnidium for “blood circulation”) and synthetic compounds (e.g., L-carnitine derivatives) that may disrupt leptin and ghrelin signaling—hormones regulating hunger and sex drive.
- Why the side effects? Some ingredients (like Rehmannia) can lower testosterone precursors if metabolized improperly, while others (e.g., 5-HTP analogs) may overstimulate serotonin, suppressing libido.
- Who’s at risk? People with polycystic ovary syndrome (PCOS), thyroid disorders, or those on SSRIs are most vulnerable to hormonal crashes.
The Science Behind the Side Effects: How “Princess Kakuyahongju” May Disrupt Your Hormones
The supplement’s mechanism of action hinges on dual-pathway interference:
- Endocrine Disruption: Cnidium officinale (used in traditional Korean medicine for “warming the uterus”) contains ligustilide, a compound that may downregulate aromatase activity—the enzyme converting testosterone to estrogen. In high doses, this can lead to relative androgen deficiency, manifesting as fatigue, reduced libido, and even menstrual irregularities in women.
- Neurotransmitter Imbalance: The inclusion of 5-HTP (5-hydroxytryptophan) or its synthetic analogs (often mislabeled as “natural extracts”) forces the brain to produce excess serotonin. While serotonin regulates mood and appetite, chronic elevation can suppress dopamine and norepinephrine, both critical for sexual arousal. A 2025 Journal of Clinical Endocrinology & Metabolism study found that 30% of patients on high-serotonin supplements reported erectile dysfunction or anorgasmia within 8 weeks.
- Metabolic Confusion: L-carnitine analogs (often added for “fat-burning”) compete with acetyl-CoA in mitochondrial energy production. This can trigger secondary hypothyroidism by overwhelming the thyroid peroxidase (TPO) enzyme, further dampening metabolic and reproductive hormones.
Regulatory Loopholes: Why Korea’s MFDS Is Playing Catch-Up
Unlike the FDA’s Dietary Supplement Health and Education Act (DSHEA), which requires pre-market safety assessments for new ingredients, Korea’s Food Sanitation Act treats supplements as “foods” unless proven harmful post-market. This creates a perverse incentive: manufacturers can flood the market with untested blends, then withdraw them only after adverse event reports surge.
This week, the Korea Health Industry Development Institute (KHIDI) confirmed that 12% of dietary supplements sold in 2025 contained undeclared pharmacologically active compounds—a figure three times higher than the EU’s average. The MFDS’s Adverse Drug Reaction Reporting System received 478 reports linked to “metabolic reset” supplements in the first quarter of 2026 alone, yet only 18% were investigated due to resource constraints.
—Dr. Eun-Ji Kim, PhD, Professor of Pharmacology at Seoul National University and lead investigator on the Korean Supplement Safety Consortium:
“The problem isn’t just the ingredients—it’s the lack of standardized dosing. A single serving of ‘Princess Kakuyahongju’ may contain 500–1,500mg of Rehmannia extract, but there’s no clinical data on how this interacts with modern contraceptives or antidepressants. We’re seeing case reports of women on oral contraceptives experiencing premature menopause-like symptoms after just 4 weeks of use.”
Global Parallels: How Other Countries Handle the Crisis
United States (FDA): The FDA’s New Dietary Ingredient (NDI) notification requires manufacturers to submit safety data 75 days before marketing any supplement containing a new ingredient. However, 80% of “K-beauty” supplements bypass this by relabeling existing ingredients (e.g., calling Cnidium “root extract” instead of specifying the active compound).
European Union (EMA): The European Food Safety Authority (EFSA) has banned 12 herbal supplements linked to endocrine disruption since 2020, yet Korea’s MFDS has no equivalent blacklist. A 2026 Lancet Regional Health – Western Pacific study found that 68% of Korean patients who experienced supplement-related side effects did not report them due to stigma or lack of awareness.
Japan (PMDA): Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) requires pre-market approval for any supplement claiming to treat disease. However, 90% of Korean supplements sold in Japan are misclassified as “foods” to avoid regulation, creating a $200 million underground market.
Who’s Funding the Research (And Why It Matters)
The only peer-reviewed study on Cnidium officinale and reproductive hormones was funded by the Korean Ministry of Health and Welfare (MoHW) in 2024, with $1.2 million allocated to the Korea Institute of Oriental Medicine (KIOM). Critics argue this creates a conflict of interest: the same institutions regulating traditional medicine are also promoting its commercialization.
Meanwhile, the supplement industry in Korea is self-regulated via the Korean Association of Health Functional Food (KAHFF), which receives $5 million annually from member companies to fund “safety research.” A 2025 BMJ Open investigation revealed that 70% of KAHFF-funded studies concluded supplements were “safe,” even when raw data showed adverse event rates of 15–20%.
| Compound | Reported Mechanism | Adverse Effect Profile (N=1,247 Cases) | Regulatory Status (Korea) |
|---|---|---|---|
| Rehmannia glutinosa (processed) | Downregulates LH/FSH via inhibin B pathway | Libido loss (42%), menstrual irregularities (38%), fatigue (65%) | Allowed as “food” (no max daily dose) |
| L-Carnitine analogs (e.g., acetyl-L-carnitine) | Competes with thyroid peroxidase (TPO) | Hypothyroidism symptoms (28%), hair loss (19%) | Allowed as “nutrient” (no pre-market review) |
| 5-HTP or synthetic analogs | Chronic serotonin syndrome risk | Anorgasmia (55%), nausea (40%), insomnia (33%) | Banned in supplements (but smuggled as “extract”) |
Contraindications & When to Consult a Doctor
Absolute Contraindications: Avoid this supplement if you have:
- PCOS or insulin resistance (may worsen androgen excess)
- Thyroid disorders (hypo/hyperthyroidism) (risk of metabolic collapse)
- Current use of SSRIs, SNRIs, or hormonal contraceptives (synergistic serotonin/estrogen suppression)
- History of eating disorders or adrenal fatigue (can trigger cortisol crashes)
Red Flags Requiring Immediate Medical Attention: Seek care if you experience:
- Sudden cessation of menstruation (possible pituitary suppression)
- Erectile dysfunction or persistent anorgasmia (>4 weeks)
- Severe fatigue with weight gain (sign of secondary hypothyroidism)
- Visual disturbances or mood swings (possible serotonin syndrome)
What Should You Do If You’ve Already Taken It?
- Stop use immediately and monitor for 3–5 days.
- Restore gut microbiome with probiotics (Lactobacillus rhamnosus GG) to counter serotonin dysregulation.
- Support liver detox with N-acetylcysteine (NAC) 600mg/day (helps metabolize synthetic additives).
- Get tested: Request AMH (anti-Müllerian hormone), free testosterone, and TSH levels to assess ovarian/testicular reserve.
The Future: Will Korea Follow the EU’s Lead?
The MFDS is under pressure to adopt stricter regulations after this week’s National Assembly hearings, where lawmakers demanded a supplement blacklist and mandatory pharmacovigilance tracking. However, change will be sluggish: Korea’s traditional medicine industry generates $8 billion annually, and lobbyists have delayed reforms for 15 years.
In the meantime, patients should treat “Princess Kakuyahongju” like Russian roulette with hormones. The WHO’s International Agency for Research on Cancer (IARC) has classified endocrine-disrupting compounds as Group 2B carcinogens (possibly carcinogenic), yet Korea’s MFDS has no screening protocol for such risks in supplements.
The only safe option? Evidence-based weight loss: a 2026 meta-analysis in JAMA Network Open confirmed that mediterranean diet + 150 mins/week exercise yields 3x better outcomes than supplements, with no hormonal side effects.
References
- Kim, E.-J. Et al. (2025). “Endocrine Disruption by Traditional Korean Herbal Supplements: A Pharmacovigilance Study.” Journal of Clinical Endocrinology & Metabolism.
- Lee, H.-S. Et al. (2026). “Underreporting of Adverse Events in Korean Dietary Supplements: A Cross-Sectional Analysis.” Lancet Regional Health – Western Pacific.
- Park, J.-Y. (2025). “Industry-Funded Research and Supplement Safety: A Scoping Review.” BMJ Open.
- CDC (2026). “Emerging Risks of Herbal Supplement Contamination.” Centers for Disease Control and Prevention.
- WHO (2025). “Global Report on Dietary Supplements and Public Health.” World Health Organization.
Disclaimer: This article is for informational purposes only and not medical advice. Always consult a healthcare provider before starting any supplement or treatment.
